Differential aerobic exercise-induced changes in plasma aldosterone between African Americans and Caucasians

Experimental Physiology

Volumn 92, Issue 5, 2007, Pages 871-879

  Jones, Jennifer M ^a,e   Dowling, Thomas C ^b   Park, Jung Jun ^a   Phares, Dana A ^a   Park, Joon Young ^a   Obisesan, Thomas O ^c   Brown, Michael D ^a,d  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d TEMPLE UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; SODIUM ION;

ABDOMINAL FAT; ADULT; AEROBIC EXERCISE; AFRICAN AMERICAN; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CAUCASIAN; CLINICAL ARTICLE; DIET RESTRICTION; ETHNICITY; FEMALE; HUMAN; HYPERTENSION; MALE; OXYGEN CONSUMPTION; RADIOIMMUNOASSAY; SODIUM EXCRETION; SUPINE POSITION;

EID: 34548026028     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2007.037408     Document Type: Article

References (47)

1. American College of Sports Medicine (2000). ACSM's Guidelines for Exercise Testing and Prescription, 6th edn. Williams & Wilkins, Baltimore.
2. Arima S, Kohagura K, Xu HL, Sugawara A, Uruno A, Satoh F, Takeuchi K & Ito S (2004). Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole. Hypertension 43, 352 357.
3. Braith RW, Welsch MA, Feigenbaum MS, Kluess HA & Pepine CJ (1999). Neuroendocrine activation in heart failure is modified by endurance exercise training. J Am Coll Cardiol 34, 1170 1175.
4. Brown MD, Moore GE, Korytkowski MT, McCole SD & Hagberg JM (1997). Improvement of insulin sensitivity by short-term exercise training in hypertensive African American women. Hypertension 30, 1549 1553.
5. Cartledge S & Lawson N (2000). Aldosterone and renin measurements. Ann Clin Biochem 37, 262 278.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr & Roccella EJ (2003). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289, 2560 2572.
7. Cononie CC, Graves JE, Pollock ML, Phillips MI, Sumners C & Hagberg JM (1991). Effect of exercise training on blood pressure in 70- to 79-yr-old men and women. Med Sci Sports Exerc 23, 505 511.
8. Cortes P, Fardella C, Oestreicher E, Gac H, Mosso L, Soto J, Foradori A, Claverie X, Ahuad J & Montero J (2000). Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach [in Spanish]. Rev Med Chil 128, 955 961.
9. DiBona GF (1989). Neural control of renal function: cardiovascular implications. Hypertension 13, 539 548.
10. Dubbert PM, Martin JE, Cushman WC, Meydrech EF & Carroll RG (1994). Endurance exercise in mild hypertension: effects on blood pressure and associated metabolic and quality of life variables. J Hum Hypertens 8, 265 272.
11. Duprez DA (2007). Aldosterone and the vasculature: mechanisms mediating resistant hypertension. J Clin Hypertens (Greenwich) 9, 13 18.
12. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA & Bornstein SR (2003). Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A 100, 14211 14216.
13. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC & Sharma AM (2005). Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45, 356 362.
14. Fiebeler A & Luft FC (2005). The mineralocorticoid receptor and oxidative stress. Heart Fail Rev 10, 47 52.
15. Fisher ND, Gleason RE, Moore TJ, Williams GH & Hollenberg NK (1994). Regulation of aldosterone secretion in hypertensive blacks. Hypertension 23, 179 184.
16. Forrester T, McFarlane-Anderson N, Bennett FI, Wilks R, Cooper R, Rotimi C, Morrison L & Ward R (1997). The angiotensin converting enzyme and blood pressure in Jamaicans. Am J Hypertens 10, 519 524.
17. Giacchetti G, Faloia E, Mariniello B, Sardu C, Gatti C, Camilloni MA, Guerrieri M & Mantero F (2002). Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 15, 381 388.
18. Gilders RM, Voner C & Dudley GA (1989). Endurance training and blood pressure in normotensive and hypertensive adults. Med Sci Sports Exerc 21, 629 636.
19. Goodfriend TL, Kelley DE, Goodpaster BH & Winters SJ (1999). Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res 7, 355 362.
20. Grim CE, Cowley AW Jr., Hamet P, Gaudet D, Kaldunski ML, Kotchen JM, Krishnaswami S, Pausova Z, Roman R, Tremblay J & Kotchen TA (2005). Hyperaldosteronism and hypertension: ethnic differences. Hypertension 45, 766 772.
21. th edn. 19, 201 209 W. B. Saunders Company, Philadelphia.
22. Hagberg JM, Montain SJ, Martin WH 3rd & Ehsani AA (1989). Effect of exercise training in 60- to 69-year-old persons with essential hypertension. Am J Cardiol 64, 348 353.
23. Hall JE, Coleman TG & Guyton AC (1989). The renin-angiotensin system. Normal physiology and changes in older hypertensives. J Am Geriatr Soc 37, 801 813.
24. He FJ, Markandu ND, Sagnella GA & MacGregor GA (1998). Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension 32, 820 824.
25. Hespel P, Lijnen P, Van Hoof R, Fagard R, Goossens W, Lissens W, Moerman E & Amery A (1988). Effects of physical endurance training on the plasma renin-angiotensin-aldosterone system in normal man. J Endocrinol 116, 443 449.
26. Hurwitz S, Cohen RJ & Williams GH (2004). Diurnal variation of aldosterone and plasma renin activity: timing relation to melatonin and cortisol and consistency after prolonged bed rest. J Appl Physiol 96, 1406 1414.
27. Jones J, Park JJ, Dowling T, Phares D, Park JY & Brown M (2006). Role of potassium excretion and percent body fat on ethnic differences in plasma aldosterone levels. Ethn Dis 16, S4-10 54-14.
28. Kiyonaga A, Arakawa K, Tanaka H & Shindo M (1985). Blood pressure and hormonal responses to aerobic exercise. Hypertension 7, 125 131.
29. Kley HK, Schlaghecke R & Kruskemper HL (1985). Stability of steroids in plasma over a 10-year period [in German]. J Clin Chem Clin Biochem 23, 875 878.
30. Kohno K, Matsuoka H, Takenaka K, Miyake Y, Nomura G & Imaizumi T (1997). Renal depressor mechanisms of physical training in patients with essential hypertension. Am J Hypertens 10, 859 868.
31. Langford HG, Cushman WC & Hsu H (1991). Chronic effect of KCl on black-white differences in plasma renin activity, aldosterone, and urinary electrolytes. Am J Hypertens 4, 399 403.
32. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N & Roth D (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130, 461 470.
33. Oberleithner H (2004). Unorthodox sites and modes of aldosterone action. News Physiol Sci 19, 51 54.
34. Oberleithner H (2005). Aldosterone makes human endothelium stiff and vulnerable. Kidney Int 67, 1680 1682.
35. Passino C, Severino S, Poletti R, Piepoli MF, Mammini C, Clerico A, Gabutti A, Nassi G & Emdin M (2006). Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 47, 1835 1839.
36. Pratt JH, Jones JJ, Miller JZ, Wagner MA & Fineberg NS (1989). Racial differences in aldosterone excretion and plasma aldosterone concentrations in children. N Engl J Med 321, 1152 1157.
37. Radosevich D (2005). Designing an Outcomes Research Study. In Understanding Health Care Outcomes, 2nd edn, ed. Kane R, pp. 23 57. Jones & Bartlett Publishers, Inc.
38. Roman O, Camuzzi AL, Villalon E & Klenner C (1981). Physical training program in arterial hypertension. A long-term prospective follow-up. Cardiology 67, 230 243.
39. Schmidt BM, Oehmer S, Delles C, Bratke R, Schneider MP, Klingbeil A, Fleischmann EH & Schmieder RE (2003). Rapid nongenomic effects of aldosterone on human forearm vasculature. Hypertension 42, 156 160.
40. Seals DR & Reiling MJ (1991). Effect of regular exercise on 24-hour arterial pressure in older hypertensive humans. Hypertension 18, 583 592.
41. Seals DR, Silverman HG, Reiling MJ & Davy KP (1997). Effect of regular aerobic exercise on elevated blood pressure in postmenopausal women. Am J Cardiol 80, 49 55.
42. Stewart PM (1999). Mineralocorticoid hypertension. Lancet 353, 1341 1347.
43. Suh A, DeJesus E, Rosner K, Lerma E, Yu W, Young JB & Rosa RM (2004). Racial differences in potassium disposal. Kidney Int 66, 1076 1081.
44. Takeda R, Hatakeyama H, Takeda Y, Iki K, Miyamori I, Sheng WP, Yamamoto H & Blair IA (1995). Aldosterone biosynthesis and action in vascular cells. Steroids 60, 120 124.
45. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ & Levy D (2004). Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 351, 33 41.
46. Winnicki M, Bonso E, Dorigatti F, Longo D, Zaetta V, Mattarei M, D'Este D, Laurini G, Pessina AC & Palatini P (2006). Effect of body weight loss on blood pressure after 6 years of follow-up in stage 1 hypertension. Am J Hypertens 19, 1103 1109.
47. Zozaya J, Viloria M & Castro A (1987). Essential arterial hypertension: plasma and urinary aldosterone alterations. Southern Med J 80, 1224 1227.